Jefferies Group LLC Amneal Pharmaceuticals, Inc. Transaction History

Jefferies Group LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$3.01 - $4.46 $89,649 - $132,836	29,784 Added 192.68%	45,242 $5,000
Q1 2022 May 16, 2022	BUY	$3.9 - $4.89 $2,421 - $3,036	621 Added 4.19%	15,458 $2,000
Q4 2021 Feb 14, 2022	BUY	$3.95 - $5.85 $58,606 - $86,796	14,837 New	14,837 $34,000
Q3 2019 Nov 13, 2019	SELL	$2.29 - $7.1 $155,456 - $481,983	-67,885 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$6.44 - $14.29 $437,179 - $970,076	67,885 New	67,885 $487,000
Q1 2019 May 15, 2019	SELL	$11.87 - $14.84 $126,391 - $158,016	-10,648 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$13.09 - $21.49 $139,382 - $228,825	10,648 New	10,648 $144,000

185

141M

57K

49K

Ticker AMRX
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 151,408,992
Market Cap $1.27B
Description
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.